Eli Lilly EPS - Earnings per Share 2010-2024 | LLY

Eli Lilly earnings per share (EPS) for the twelve months ending June 30, 2024 was $8.12, a 12.93% increase year-over-year.

  • Eli Lilly EPS for the quarter ending June 30, 2024 was $3.28, a 68.21% increase year-over-year.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.
  • Eli Lilly 2021 annual EPS was $6.12, a 9.87% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Eli Lilly EPS - Earnings per Share 2010-2024 | LLY

  • Eli Lilly EPS for the quarter ending June 30, 2024 was $3.28, a 68.21% increase year-over-year.
  • Eli Lilly 2023 annual EPS was $5.8, a 15.94% decline from 2022.
  • Eli Lilly 2022 annual EPS was $6.9, a 12.75% increase from 2021.
  • Eli Lilly 2021 annual EPS was $6.12, a 9.87% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B